335 related articles for article (PubMed ID: 16945958)
1. Competition for RISC binding predicts in vitro potency of siRNA.
Koller E; Propp S; Murray H; Lima W; Bhat B; Prakash TP; Allerson CR; Swayze EE; Marcusson EG; Dean NM
Nucleic Acids Res; 2006; 34(16):4467-76. PubMed ID: 16945958
[TBL] [Abstract][Full Text] [Related]
2. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
Yoo JW; Kim S; Lee DK
Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
[TBL] [Abstract][Full Text] [Related]
3. RNA helicase A is not required for RISC activity.
Liang XH; Crooke ST
Biochim Biophys Acta; 2013 Oct; 1829(10):1092-101. PubMed ID: 23895878
[TBL] [Abstract][Full Text] [Related]
4. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
[TBL] [Abstract][Full Text] [Related]
5. 2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.
Wu SY; Yang X; Gharpure KM; Hatakeyama H; Egli M; McGuire MH; Nagaraja AS; Miyake TM; Rupaimoole R; Pecot CV; Taylor M; Pradeep S; Sierant M; Rodriguez-Aguayo C; Choi HJ; Previs RA; Armaiz-Pena GN; Huang L; Martinez C; Hassell T; Ivan C; Sehgal V; Singhania R; Han HD; Su C; Kim JH; Dalton HJ; Kovvali C; Keyomarsi K; McMillan NA; Overwijk WW; Liu J; Lee JS; Baggerly KA; Lopez-Berestein G; Ram PT; Nawrot B; Sood AK
Nat Commun; 2014 Mar; 5():3459. PubMed ID: 24619206
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC.
Castanotto D; Sakurai K; Lingeman R; Li H; Shively L; Aagaard L; Soifer H; Gatignol A; Riggs A; Rossi JJ
Nucleic Acids Res; 2007; 35(15):5154-64. PubMed ID: 17660190
[TBL] [Abstract][Full Text] [Related]
7. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
[TBL] [Abstract][Full Text] [Related]
8. Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cells.
Vickers TA; Lima WF; Nichols JG; Crooke ST
Nucleic Acids Res; 2007; 35(19):6598-610. PubMed ID: 17905815
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo.
Foster DJ; Barros S; Duncan R; Shaikh S; Cantley W; Dell A; Bulgakova E; O'Shea J; Taneja N; Kuchimanchi S; Sherrill CB; Akinc A; Hinkle G; Seila White AC; Pang B; Charisse K; Meyers R; Manoharan M; Elbashir SM
RNA; 2012 Mar; 18(3):557-68. PubMed ID: 22294662
[TBL] [Abstract][Full Text] [Related]
10. Short interfering RNA strand selection is independent of dsRNA processing polarity during RNAi in Drosophila.
Preall JB; He Z; Gorra JM; Sontheimer EJ
Curr Biol; 2006 Mar; 16(5):530-5. PubMed ID: 16527750
[TBL] [Abstract][Full Text] [Related]
11. Identification of sequence features that predict competition potency of siRNAs.
Li X; Yoo JW; Lee JH; Hahn Y; Kim S; Lee DK
Biochem Biophys Res Commun; 2010 Jul; 398(1):92-7. PubMed ID: 20558136
[TBL] [Abstract][Full Text] [Related]
12. RNA interference using boranophosphate siRNAs: structure-activity relationships.
Hall AH; Wan J; Shaughnessy EE; Ramsay Shaw B; Alexander KA
Nucleic Acids Res; 2004; 32(20):5991-6000. PubMed ID: 15545637
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways.
Okamura K; Ishizuka A; Siomi H; Siomi MC
Genes Dev; 2004 Jul; 18(14):1655-66. PubMed ID: 15231716
[TBL] [Abstract][Full Text] [Related]
14. The preferred route for the degradation of silencing target RNAs in transgenic plants depends on pre-established silencing conditions.
Sanders M; Lannoo N; Maddelein W; Depicker A; Van Montagu M; Cornelissen M; Jacobs J
Nucleic Acids Res; 2004; 32(11):3400-9. PubMed ID: 15220468
[TBL] [Abstract][Full Text] [Related]
15. A protein sensor for siRNA asymmetry.
Tomari Y; Matranga C; Haley B; Martinez N; Zamore PD
Science; 2004 Nov; 306(5700):1377-80. PubMed ID: 15550672
[TBL] [Abstract][Full Text] [Related]
16. CCR4-NOT deadenylates mRNA associated with RNA-induced silencing complexes in human cells.
Piao X; Zhang X; Wu L; Belasco JG
Mol Cell Biol; 2010 Mar; 30(6):1486-94. PubMed ID: 20065043
[TBL] [Abstract][Full Text] [Related]
17. The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analogues.
Deleavey GF; Frank F; Hassler M; Wisnovsky S; Nagar B; Damha MJ
Nucleic Acid Ther; 2013 Feb; 23(1):81-7. PubMed ID: 23289589
[TBL] [Abstract][Full Text] [Related]
18. Competition between siRNA duplexes: impact of RNA-induced silencing complex loading efficiency and comparison between conventional-21 bp and Dicer-substrate siRNAs.
Tanudji M; Machalek D; Arndt GM; Rivory L
Oligonucleotides; 2010 Feb; 20(1):27-32. PubMed ID: 19943801
[TBL] [Abstract][Full Text] [Related]
19. siRNAs targeted to certain polyadenylation sites promote specific, RISC-independent degradation of messenger RNAs.
Vickers TA; Crooke ST
Nucleic Acids Res; 2012 Jul; 40(13):6223-34. PubMed ID: 22422842
[TBL] [Abstract][Full Text] [Related]
20. Conversion of pre-RISC to holo-RISC by Ago2 during assembly of RNAi complexes.
Kim K; Lee YS; Carthew RW
RNA; 2007 Jan; 13(1):22-9. PubMed ID: 17123955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
